• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多药化疗期间阿霉素心脏毒性的超声心动图评估(作者译)

[Echocardiographic evaluation of adriamycin cardiotoxicity during polychemotherapy (author's transl)].

作者信息

Christmann D, Bareiss P, Boilletot A, Bergerat J P, Oberling F

出版信息

Nouv Rev Fr Hematol (1978). 1981;23(3):149-54.

PMID:7290990
Abstract

Left ventricular function in 21 patients treated by polychemotherapy including adriamycin (ADM) has been studied by repeated echocardiographic examination. The mean rate of circumferential, the ejection fraction, and the shortening fraction are the most significant data obtained by this investigation. They permit the detection of early damage of left ventricular performance which increases progressively, confirming the dose-dependent nature of the cardiomyopathy. Supervision of patients under ADM is necessary to recognize those who rapidly develop cardiomyopathy. In these cases, treatment interruption may be beneficial. In contrast, patients with little left ventricular damage can be treated by a total dosage of ADM superior to that actually recommended.

摘要

对21例接受包括阿霉素(ADM)在内的多药化疗的患者,通过反复超声心动图检查研究了左心室功能。圆周平均速率、射血分数和缩短分数是本次研究获得的最重要数据。它们能够检测到左心室功能的早期损害,且这种损害会逐渐加重,证实了心肌病的剂量依赖性。对接受ADM治疗的患者进行监测,对于识别那些迅速发展为心肌病的患者很有必要。在这些情况下,中断治疗可能有益。相比之下,左心室损害较小的患者可以接受高于实际推荐剂量的ADM总剂量治疗。

相似文献

1
[Echocardiographic evaluation of adriamycin cardiotoxicity during polychemotherapy (author's transl)].多药化疗期间阿霉素心脏毒性的超声心动图评估(作者译)
Nouv Rev Fr Hematol (1978). 1981;23(3):149-54.
2
[Noninvasive cardia fúnction diagnosis in children treated with adriamycin (author's transl)].阿霉素治疗儿童的无创心功能诊断(作者译)
Klin Padiatr. 1980 Nov;192(6):502-8. doi: 10.1055/s-2008-1035634.
3
Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity.无创心脏参数在阿霉素心脏毒性检测与评估中的对比分析。
Johns Hopkins Med J. 1981 Aug;149(2):57-63.
4
Adriamycin cardiotoxicity: early detection by systolic time interval and possible prevention by coenzyme Q10.阿霉素心脏毒性:通过收缩期时间间期进行早期检测以及辅酶Q10的可能预防作用。
Cancer Treat Rep. 1978 Jun;62(6):887-91.
5
[Echocardiography with angiotensin administration in the diagnosis of adriamycin-induced cardiomyopathy].[血管紧张素给药超声心动图在阿霉素诱导的心肌病诊断中的应用]
Z Kardiol. 1989 May;78(5):320-7.
6
[Abnormal left-ventricular contraction and filling in patients receiving adriamycin for solid tumours (author's transl)].实体肿瘤患者接受阿霉素治疗时左心室收缩和充盈异常(作者译)
Dtsch Med Wochenschr. 1978 Sep 8;103(36):1408-12. doi: 10.1055/s-0028-1129273.
7
Reduction of cardiac toxicity of anthracyclines by L-carnitine: preliminary overview of clinical data.
Int J Clin Pharmacol Res. 1985;5(2):137-42.
8
Echocardiographic assessment of anthracycline cardiotoxicity during different therapeutic regimens.
Int J Clin Pharmacol Res. 1987;7(4):307-11.
9
Echocardiographic evaluation of adriamycin cardiotoxicity in children.儿童阿霉素心脏毒性的超声心动图评估
Cancer Treat Rep. 1976 Sep;60(9):1281-4.
10
[Damage of left ventricular function after treatment with doxorubicin in patients with malignant lymphomas].
Vnitr Lek. 2000 Nov;46(11):768-75.